The unfulfilled promise of the antidepressant medications

Medical Journal of Australia

Volumn 204, Issue 9, 2016, Pages 348-350.e1

  Davey, Christopher G ^a,b   Chanen, Andrew M ^a,b  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; ZIMELDINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DISEASE SEVERITY; DSM-III; EXERCISE; MENTAL HEALTH; MONOTHERAPY; NERVE STIMULATION; NEUROPSYCHOLOGY; POLYPHARMACY; PREVALENCE; PSYCHOTHERAPY; SOCIAL WORKER; TRAINING; TRANSCRANIAL MAGNETIC STIMULATION; AUSTRALIA; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGY; HEALTH CARE DELIVERY; HUMAN; MEDICARE; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; STANDARDS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ANTIDEPRESSIVE AGENTS; AUSTRALIA; DEPRESSIVE DISORDER, MAJOR; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEDICARE; MENTAL HEALTH SERVICES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84968911206     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja16.00194     Document Type: Article

References (33)

1. Andrews G, Sanderson K, Corry J, Lapsley HM. Using epidemiological data to model efficiency in reducing the burden of depression. J Ment Health Policy Econ 2000; 3: 175-186.
2. Organisation of Economic Co-operation and Development. Pharmaceutical market, 2016. http://dx.doi.org/10.1787/data-00545-en (accessed Feb 2016).
3. Lacasse JR, Leo J. Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med 2005; 2: e392.
4. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5: e45.
5. Leucht S, Hierl S, Kissling W, et al. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry 2012; 200: 97-106.
6. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358: 252-260.
7. Kessel M. Restoring the pharmaceutical industry’s reputation. Nat Biotechnol 2014; 32: 983-990.
8. Olfson M, Blanco C, Wang S, et al. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry 2014; 71: 81-90.
9. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297: 1683-1696.
10. Le Noury J, Nardo JM, Healy D, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015; 351: h4320.
11. Sharma T, Guski LS, Freund N, Gøtzsche PC. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 2016; 352: i65.
12. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002; 287: 1840-1847.
13. Khan A, Schwartz K, Kolts RL, et al. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes. Biol Psychiatry 2007; 62: 65-71.
14. Sinyor M, Levitt AJ, Cheung AH, et al. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry 2010; 71: 270-279.
15. Johnsen TJ, Friborg O. The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: a meta-analysis. Psychol Bull 2015; 141: 747-768.
16. Klein JB, Jacobs RH, Reinecke MA. Cognitive-behavioral therapy for adolescent depression: a meta-analytic investigation of changes in effect-size estimates. J Am Acad Child Adolesc Psychiatry 2007; 46: 1403-1413.
17. Cuijpers P, van Straten A, Bohlmeijer E, et al. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010; 40: 211-223.
18. Opie RS, O’Neil A, Itsiopoulos C, Jacka FN. The impact of whole-of-diet interventions on depression and anxiety: a systematic review of randomised controlled trials. Public Health Nutr 2015; 18: 2074-2093.
19. Krogh J, Nordentoft M, Sterne JA, Lawlor DA. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2011; 72: 529-538.
20. Jacka FN, Berk M. Depression, diet and exercise. Med J Aust 2012; 1: 21-23. https://www.mja.com.au/journal/2013/199/6/depression-diet-and-exercise
21. Cuijpers P, Sijbrandij M, Koole SL, et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 2014; 13: 56-67.
22. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitivebehavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004; 292: 807-820.
23. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010; 67: 1265-1273.
24. Meadows GN, Enticott JC, Inder B, et al. Better access to mental health care and the failure of the Medicare principle of universality. Med J Aust 2015; 202: 190-194. https://www.mja.com.au/journal/2015/202/4/better-access-mental-healthcare-and-failure-medicare-principle-universality
25. Harris MG, Diminic S, Reavley N, et al. Males’ mental health disadvantage: an estimation of gender-specific changes in service utilisation for mental and substance use disorders in Australia. Aust N Z J Psychiatry 2015; 49: 821-832.
26. Parker S, Bylett M, Leggett A. Challenges faced by trainee psychiatrists working towards competency in psychotherapies. Australas Psychiatry 2013; 21: 56-59.
27. Hyman SE. Revolution stalled. Sci Transl Med 2012; 4: 155cm11.
28. Carroll BJ. Bringing back melancholia. Bipolar Disord 2012; 14: 1-5.
29. Lewis AJ. Melancholia: a clinical survey of depressive states. J Ment Sci 1934; 80: 277-378.
30. Arnow BA, Blasey C, Williams LM, et al. Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial. Am J Psychiatry 2015; 172: 743-750.
31. Vittengl JR, Jarrett RB, Weitz E, et al. Divergent outcomes in cognitive-behavioral therapy and pharmacotherapy for adult depression. Am J Psychiatry 2016. In-press.
32. Hansen R, Gaynes B, Thieda P, et al. Meta-analysis of major depressive disorder relapse and recurrence with secondgeneration antidepressants. Psychiatr Serv 2008; 59: 1121-1130.
33. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015; 49: 1087-1206